secwatch.observer — SEC 8-K summary
======================================

Issuer:     iBio, Inc. (IBIO)
CIK:        0001420720
Form:       8-K
Filed at:   2023-12-08T23:59:59+00:00
Accession:  0001420720-23-000068
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

iBio closes public offering of common stock and warrants, raising ~$4.5M gross proceeds
--------------------------------------------------------------------------------

- Offering included 600K shares common stock, 1.65M pre-funded warrants, and 4.5M Series C/D warrants exercisable at $2.00.
- Gross proceeds of ~$4.5M; net proceeds for working capital, R&D, trial preparation, and severance payments.
- Placement agents A.G.P./Alliance Global Partners (lead) and Brookline Capital Markets receive 5.5% cash fee plus expense reimbursement.
- Tail warrants issued to H.C. Wainwright for 131,820 shares at $2.50 exercise price if certain investors participate.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1420720/000142072023000068/0001420720-23-000068-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1420720/000142072023000068/ibio-20231207x8k.htm
  HTML page:      https://secwatch.observer/filing/0001420720-23-000068

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer